... to have atypical mutations had a more limited response. None of the atypical cases had tumor shrinkage, but the majority had disease stabilization for a period of time. Two patients who experienced ...
... cell-growth pathways – led to significant tumor shrinkage in mice with lung cancer driven by ... MEK inhibitor alone caused only a modest reduction in tumor size, but combined treatment with both agents ...
... than those who don’t, and this treatment allows us to reduce the tumor size prior to surgery.”
Given the evidence of tumor-shrinkage from the initial treatment, Dr. Moser and his ...
... effects or disease progression. The primary treatment outcome was radiographic evidence of tumor shrinkage as determined by an independent review. The researchers also analyzed the duration of tumor ...
... cycles of platinum-based chemotherapy. Those patients who have had a response to the treatment, meaning either tumor shrinkage or stable disease, may be eligible. The trial is a double-blind, placebo- ...
GENEVA, Switzerland, Oct. 23 (UPI) -- U.S. scientists say an early trial of a multi-kinase inhibitor has shown impressive tumor shrinkage in patients with a hard-to-treat form of thyroid cancer.
Preliminary trials of a new multi-kinase inhibitor have indicated it has impressive tumor shrinkage activity in patients with a difficult to treat type of thyroid cancer. The results have put the drug ...
... -small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard ...
... -small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard ...
... cancer. Women who were given the drug, Zometa, as part of their initial treatment had greater tumor shrinkage and were less likely to need radical surgery, according to a preliminary study reported ...
... found that both compounds worked well in cells in culture, shrank tumors in mice, maintained tumor shrinkage for months, and prevented the androgen receptor from activating additional genes later in ...
... shrank until it was undetectable), two patients had partial tumor shrinkage and 17 patients showed no further growth in tumor size; that is, they had stable disease which often was durable.
A ...
... and dramatic benefit from pazopanib, while another one-third experienced stabilization of their cancer or some tumor shrinkage. The remaining one-third of patients did not benefit from the drug. The ...
... samples from NF2-related schwannomas, sporadic tumors not caused by NF2 and normal spinal nerves, ... 16 months. In one patient without significant tumor shrinkage or hearing improvement (he had lost ...
... with a range of 71 to 84 years. Four patients have had partial responses with demonstrable tumor shrinkage and three patients had stable disease by RECIST criteria.
The combination appears safe and ...
